Company: SMNR
Filing Date: 2025-06-11
Form Type: S-4/A
Source: 0001193125-25-139124
Chunk: 37

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-06-11
Form: S-4/A
Chunk 37
---
 the domicile of Denali pursuant to a transfer by way of continuation of an exempted company out of the Cayman Islands and a domestication into the State of Delaware as a corporation, and the de-registration of Denali in the Cayman Islands. |

| • |     | “Effective Time” means the time at which the Business Combination becomes effective. |

| • |     | “Exchange Act” means the Securities Exchange Act of 1934, as amended. |

| • |     | “EF Hutton” means EF Hutton LLC, the representative of the underwriters in the IPO. |

| • |     | “founder shares” means the 1,562,500 issued and outstanding Denali Class B Ordinary Shares held by the Sponsor and the following directors of Denali: Lei Huang, You (“Patrick”) Sun, Huifeng Chang, Jim Mao and Kevin Vassily, initially issued in a private placement prior to IPO, and the Denali Class A Ordinary Shares that will be issued upon the automatic conversion of the Denali Class B Ordinary Shares at the time of the Business Combination. |

| • |     | “GAAP” means accounting principles generally accepted in the United States of America. |

| • |     | “HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. |

| • |     | “Initial Shareholders” means the Sponsor and the holders of founder shares. |

| • |     | “IPO” refers to the initial public offering of 8,250,000 Public Units of Denali consummated on April 11, 2022. |

| • |     | “IRS” means the United States Internal Revenue Service. |

| • |     | “Merger Sub” means Denali Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Denali. |

| • |     | “Nasdaq” means The Nasdaq Stock Market LLC. |

2

| • |     | “Nasdaq De-Listing” means the de-listing of the Public Units, Denali Class A Ordinary Shares and Public Warrants from trading on Nasdaq for any reason, including due to the failure of Denali to satisfy Nasdaq’s continued listing requirements pursuant to Nasdaq Listing Rule 5450(b)(2)(A) and Listing Rule IM-5101-2(b). |

| • |     | “Nasdaq Listing Rules” means the rules and listing standards